Who qualifies for GLP-1 weight loss medications?
Educational only: This page is for general education—not personal medical advice, diagnosis, or treatment. See a licensed clinician for your situation.
Short answer
Eligibility generally follows FDA indications: typically BMI thresholds with comorbidities, or higher BMI cutoffs—plus no contraindications (certain thyroid cancers, pancreatitis history, pregnancy, etc.). A licensed clinician reviews labs, medications, and goals before prescribing.
Detailed answer
Insurance coverage criteria may be stricter than FDA labeling.
Persistent fatigue, cravings, or weight change despite “normal” screening labs?
Yes → Discuss metabolic labs, sleep history, and GLP-1 eligibility with a clinician.
No → Continue lifestyle structure; recheck if symptoms escalate.
Severe abdominal pain, vomiting, or dehydration on GLP-1?
Yes → Contact prescriber promptly; emergency care if unable to hydrate.
Read the full guide
This Health Guide is scoped for a single FAQ-style question. Our clinical article goes deeper on evidence, risks, monitoring, and what to discuss with your clinician.
Evidence & references
- FDA indication summaries for semaglutide 2.4 mg and tirzepatide weight indications
Also read our Weight loss articles · Full clinical guide